Skip to content

MLAY

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2023

    Repeatedly fined for illegal medical ads; 3·15 exposé of "three-no" exosomes

    Tianjin Hedong Meilai was fined about 27 times in total for publishing illegal medical advertisements without review, price fraud, and failing to use medical devices as required; in 2026 CCTV's 3·15 exposed its use of "three-no" exosomes. Multiple fines.